Ulcerative colitis (UC)
Ulcerative colitis (UC) is an inflammation of the lining of the colon
(large bowel). Unlike the other major inflammatory bowel condition,
Crohn’s disease, it is limited to the colon and almost always starts
in the rectum and continues further along the colon for a variable
distance depending upon the disease severity. Around 50% of people
with UC have disease that is limited only to the rectum whilst 20%
having extensive disease affecting the majority of the colon.
Ulcerative colitis rarely affects the anal canal and abscesses and
fistulas are uncommon, unlike Crohn’s disease. Although Crohn’s and UC
represent separate diseases, about 10% of patients demonstrate
features of both conditions making a clear diagnosis difficult. This
is known as indeterminate colitis. The exact cause of UC is unclear,
it appears to be caused by an exaggerated immune response which
attacks the mucosal lining of the colon as if it were foreign tissue.
This is probably due to a combination of genetic and environmental
factors and some population groups and families are known to have a
higher risk for developing UC.

What are the symptoms of UC?
Although the symptoms and severity of UC vary greatly between
individuals, common manifestations include; rectal bleeding, passing
mucous from the rectum, abdominal pain, diarrhoea, fever and weight
loss. Although the majority of patients have chronic ongoing symptoms,
some will have severe “flare ups” of UC which require hospital
admission and may even necessitate emergency surgery to resolve, this
is known as fulminant colitis.
Some patients experience odd symptoms
that do not appear to be related to the intestine, (these are known as
extra-colonic manifestations) and include joint pain, (arthritis),
inflammation of the joints in the spine (ankylosing spondylitis),
liver disease (sclerosing cholangitis), eye problems (iritis) and
skin lesions. Patients who have longstanding UC have an increased risk
of developing colon cancer, the incidence of colon cancer being
around 5-10% in those with the disease for 10-20 years and 10-20% in
those with the disease between 20-30 years. This risk depends on the
extent of the disease and it’s severity and careful screening programs
for those with longstanding colitis are recommended (see screening).
How is UC managed?
The mainstay of UC treatment is using drug therapy, this is usually
performed by a specialist gastroenterologist. For those with disease
limited to the rectum anti-inflammatory or steroid suppositories or
enemas such as Mesalazine or Prednisolone may be all that is required.
For more extensive disease, other types of medication may be required
such as aminosalicylates which selectively deliver an aspirin like
compound to the colon.
Steroids are also effective in both the acute
phase and to maintain remission but side effects such as osteoporosis,
raised blood pressure, diabetes, adrenal suppression and cataract
formation have lead gastroenterologists to try to reduce our reliance
on them. Immunomodulation therapy with drugs such as azathioprine and
methotrexate are used successfully to reduce the patient’s steroid
requirements. More recently, medication with antibodies against
naturally occurring substances which are involved in the immune
response such as infliximab have also shown great benefit in treating
disease which would otherwise have required surgery.
When is surgery indicated?
Surgery may be undertaken as an emergency in patients who have a
“flare up” of acute colitis which does not respond to medical
treatment, often the bowel becomes massively distended and if left may
perforate, this is known as a megacolon and surgery should be
undertaken before perforation occurs. Some patients develop severe
bleeding from the colon which can not be stopped, these patient also
require an emergency operation. Other patients have colitis which
although not immediately life threatening, is poorly controlled by
medicines.
Often the colitis disrupts their life, making them
chronically unwell, whilst some have frequent “flare ups” which
require repeated hospital admissions and others are dependent upon
steroids to control the colitis. These patients should be considered
for surgery as should those with long standing UC who develop a cancer
in the colon.
What operations are available?
Historically, the standard operation for ulcerative colitis is the
proctocolectomy in which the entire colon, rectum and anus are removed
and patients have a permanent stoma (ileostomy). In the emergency
setting this may be performed in stages with the colon removed first
(subtotal colectomy) and an ileostomy formed to allow the patient to
recover from their illness and the rectum to be removed at a later
stage when the patient has returned to full health and stopped taking
any medication.
Although the proctocolectomy is an excellent procedure
which cures the disease and removes any risk of developing bowel
cancer, it does mean that the patient has a permanent stoma. Most
people would prefer not to have a stoma for the rest of their lives
and may opt to have a new “rectum” made from loops of small intestine.
This is attached to the anal canal so that they can open their bowels
without the need of a stoma and is known as an ileoanal (or Park’s)
pouch. This procedure is usually performed in 2 or 3 steps, first the
colon is removed, the pouch may be fashioned at this time or at a
subsequent procedure and a temporary ileostomy formed to allow the
pouch to heal.
The stoma is then closed a few months later in a much
simpler procedure. The pouch acts as a reservoir to store the faeces
prior to defecation. Although bowel function never returns to “normal”
and most patients experience five or so bowel movements per day and
possibly one at night, satisfaction levels are generally high. In a
small number of cases the pouch is not successful and may have to be
removed, however this is uncommon. Pouch surgery should not be
undertaken lightly and may have an impact on childbearing in young
women. You should discuss the suitability of this procedure and other
possible complications with a colorectal surgeon experienced in this
technique.
Are there any alternatives?
People may hear about the continent ileostomy or Kock pouch. This is
like an ileostomy but a pouch of small intestine is created inside the
abdomen. The benefit is that there is no need to wear a bag and the
reservoir can be emptied by a catheter 3-4 times a day however
complication and failure rates for this procedure are high and it is
very rarely performed at all nowadays. An alternative procedure has
historically been to retain the rectum and join the small bowel
directly to it. Although this avoids the need for an ileostomy it does
not treat the rectal UC and is not routinely undertaken.
Conclusion
Managing UC can be very complex and should be undertaken by a
specialist gastroenterologist in conjunction with an experienced
colorectal surgeon.
|